The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Key financial elements of the transaction
· $0.5m upfront, $0.5m on completion of the, already fully financed, Evgen-sponsored human volunteer Phase 1 study (anticipated during Q2 2023). Milestone payments up to commercial launch are $26.5m, including $5m on grant of IND by the FDA (anticipated in late 2023). Total milestones of $160.5m are payable to the Company in relation to the first neurodevelopmental disorder indication under the license. Royalties payable to Evgen on sales are in the low to medium double-digit range in all scenarios, including on-licensing by Stalicla and use of SFX-01 in further licensed indications.
Is Earlofshame surfing the top risers board again? fk me. Hilarious. What a low life. Meanwhile other people are putting energy into making some money! haha
What a shock, Earl finds a negative angle from an insanely positive RNS! It must be his job, I’ve never seen him come on any BB and post positively post any RNS! I sense that upon a £140 million euro millions win he would respond “it’s good, but it’s not £141 million pounds is it?”
Yes, all time high of just over 32p, presumably will see a brand new ATH in the coming weeks hopefully!
Yes the rise seems to have some substance . A fair bit of elevation next couple of days and the will drop until next milestone . Investors are naturally impatient so will sell and possibly come back next year . Just my opinion. Written this one off along time ago so pleasantly surprised ! Good luck all
..... and fair play to the private investors who have already seen the potential here and built notifiable stakes, Mr Kight and the Newlands etc.
Have a look at the RNS 8/6/2022. Evgen appear to be on to something with this Sulforadex technology and SFX-01. It appears to have multi-functionality. There are numerous trials and collaborations happening in Q4 2022, ie now! I think todays unexpected news is just the start, big pharma will really sit up and take note and want to team up with EVG for a piece of the action. Just read the full year results.
The way it finished today did feel like the rocket launchers were started to warm up, then again sp’s do have a tendency to inexplicably do the opposite to what you think they will! Who knows, could be chased up another 200% tomorrow if the buying pressure and volume remains as strong as today on the other hand the mm’s could play their favourite game of dropping the sp very sharply in an attempt to shake a few holders out of their shares just to sell them back later at a higher price like they did today! All you can do is DYOR and hope for a similar day to today! GL
Haha exactly. But I wouldn’t be panic selling. It’s a buy or hold for me. No advice intended.
Nobody knows. How long is a piece of string lol x
I was lucky enough to buy-in at around 8.30am after reading the 7am RNS.
Looking to buy more tomorrow or Wednesday.
What are the thoughts of the long-term holders (with more company knowledge) about the direction of travel of the SP tomorrow, so I can get in at the best price?
Do you think there will be a slight correction/pullback on the SP in the morning or will this continue to go up like a rocket on Tuesday/Wednesday.
Honest views would be greatly appreciated!
GLA and well done!
Stephen11.
Always been wary of the high percentage rise but if you do some quick research you can see when the odd one is genuine. GLA.
Never knock taking profit but you held a while underwater. Maybe hold for a few more days in profit then decide.
Sxchap. Think u may of jumped to soon
Gl with your next investment
Well i am in profit after a long while well under water. Took my profit and moved on. Good luck to those still in and hope you make a profit.
Was’nt expecting 7p today but am expecting a lot more in 2023
Wait and see but everyone to their own trades and convictions
When it gets to 7.865 I’ll break even.
I hope others got in at a lower price and are showing good profits
Did similar multi day rally back in April /May 2020 on prospects of a commercial deal albeit some of that included a fair amount of covid premium attached.
This agreement actually has some detailed numbers to consider which is the present driving force behind this move.
Always difficult to value in the early stages, but any successful outcome would see a significant re rate upwards and trigger further cash injections plus the prospects of a larger global deal.
GLA
20p + before close Wednesday would be fair under the circumstances I think.
Investor presentation Wednesday which will no doubt pull some instis in.
Like to think it could break 10-12p by close Wednesday.
Might have to revise that if trading goes well tomorrow.
NFA
GLA
Well you heard it here first FOMO Tuesday commences at 8am GLA
Presentation Wednesday could take this back to 18/20p
Fantastic day
Could do 100% tomorrow no ramp. Check fundamentals dyor.
149.12% :-)
NT first thing tomorrow surely!
7